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Background.	CIHH	is	a	genetic	syndrome	that	combines	reproductive	and	brain	abnormalities.	Up	to	now,	the	brain	phenotype	has	not	been	well	characterized.	
Methods.
- Investigation of a series of 30 patients presenting a CIHH.
- Panel of 16 genes related to hypogonadotropic hypogonadism (HH) by next
generation sequencing on a MiSeq® Instrument (Illumina) and by using a validated
targeted approach with xGen® Lockdown® Probes (IDT).
- In a second time the cohort was reviewed to search about cerebral anomalies or
hypothalamic-pituitary malformations, based on the magnetic resonance imagery
(MRI).
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In our cohort, Chiari malformation type 1 (CM1) was found in 2 of the 17 patients
(12%) who performed a brain MRI. In the general population, incidence of CM1 was
estimated at 0,7%.
CM1 is known to be associated with a series of genetic syndrome (1,2). A cohort of
patients with Costello syndrome is reported with higher incidence of CM1 (17%). In
this report, interestingly, among the three patients with Costello syndrome and
CM1, two were described with a hypogonadism.(3)
In the endocrinology field, it was currently reported that 5 to 20% of patients with
isolated growth hormone deficiency (GHD) or multiple hormone deficiency (MPHD)
presented a CM1. (4)
Etiology of CM1.
Theory of breech delivery was evocated in the past years (CM1 caused by
traction of the spinal cord during breech delivery). But further observations
disproof this mechanism.(4)
Currently, the etiology remains unclear and CM1 is most likely multifactorial.
Genetic contribution is argued by familial aggregation and twin studies.
Studies with animal models and human morphometric analyses have
suggested a mesoderm insufficiency.(5,2,6)
The abnormal development of the cerebellar tonsils occurs during the fourth
to eighth first weeks of gestation, a critical period for the formation of the
hypothalamo-pituitary region. This fact contributes to support the theory of a
defect during the embryogenesis.(4)
A case-control association study of 58 developmental genes was published in 2013.(6) The investigated genes were involved in somitogenesis, placental
angiogenesis, sclerotome development or CM1-associated syndromes. Common variants in 14 genes out of the 58 initial genes are though to confer a
susceptibility to CM1, among this 14 genes FGFR1 was reported.(6)
In our cohort, genetic analyses revealed a new FGFR1 mutation for one of our patient with CM1. This interesting result establish for the first time a correlation
between CM1 and FGFR1mutation in a context of CIHH.
